Sorbonne Université – Campus Pierre et Marie Curie (formerly UPMC), PHENIX (Physicochimie des Electrolytes et des nanosystèmes interfaciaux), Inorganic Colloids team (CIN team), 4 place Jussieu 75252 Paris Cedex 05, France
Dr. Nébéwia Griffete
Sorbonne Université – Campus Pierre et Marie Curie (formerly UPMC), PHENIX (Physicochimie des Electrolytes et des nanosystèmes interfaciaux), Inorganic Colloids team (CIN team), 4 place Jussieu 75252 Paris Cedex 05, France
Herein, original magnetic drug delivery nanomaterials for cancer therapy are developed and compared, with the purpose to show active control over drug release by using an alternative magnetic field (AMF). The rationale is to combine polymers and superparamagnetic nanoparticles to trigger such drug release under AMF. Two magnetic nanosystems are thus presented: magnetic nanogels made of thermosensitive and biocompatible polymers and core-shell nanoparticles with a magnetic core and a molecularly imprinted polymer as shell. Both encapsulate doxorubicin (DOX) and the DOX controlled release was investigated in vitro and in cells under AMF excitation. It confirms that the local heat profile at the vicinity of the iron oxide core can be used for the DOX controlled release. It also shows that both nanosystems help delivering more DOX inside the cells compared to internalization of free DOX. Finally, the DOX intracellular release could be remotely triggered under AMF, in athermal conditions, thus enhancing DOX cytotoxicity.
5 February 2018 in Journal of Materials Chemistry B
Synthesis of protein imprinted polymers coupled to magnetic nanoparticles to obtain specific recognition systems is very promising, but is still challenging.
Molecularly imprinted polymers (MIPs) have been widely used in nanomedicine in the last few years. However, their potential is limited by their intrinsic properties resulting, for instance, in lack of control in drug release processes or complex detection for in vivo imaging. Recent attempts in creating hybrid nanomaterials combining MIPs with inorganic nanomaterials succeeded in providing a wide range of new interesting properties suitable for nanomedicine. Through this review, we aim to illustrate how hybrid molecularly imprinted polymers may improve patient care with enhanced imaging, treatments, and a combination of both.
We developed a hybrid nanomaterial composed of magnetic core nanoparticles and molecularly imprinted polymer shell modified with biotin ligands to target cancer cells and release a drug under alternating magnetic field.